Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection

Spread of multidrug-resistant high-risk Klebsiella pneumoniae clones in a tertiary hospital from southern Brazil

(2017) Guilherme Bartolomeu Gonçalves et al.   INFECTION GENETICS AND EVOLUTION

Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study

(2017) Jingjing Quan et al.   LANCET INFECTIOUS DISEASES

Epidemiology of infections caused by polymyxin-resistant pathogens

(2016) Helen Giamarellou   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficient transmission of IncFII Y and IncL plasmids and Klebsiella pneumoniae ST101 clone producing OXA-48, NDM-1 or OXA-181 in Bucharest hospitals

(2016) Ilda Czobor et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Very low prevalence of MCR-1/MCR-2 plasmid-mediated colistin resistance in urinary tract Enterobacteriaceae in Switzerland

(2016) Nadia Liassine et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones ofKlebsiella pneumoniaeST11/KPC-2, ST101/KPC-2 and ST512/KPC-3

(2016) Jesús Oteo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality

(2016) Ö. Ergönül et al.   JOURNAL OF HOSPITAL INFECTION

Plasmid-mediated colistin resistance in a patient infected with Klebsiella pneumoniae

(2016) Stefan Nicolet et al.   LANCET INFECTIOUS DISEASES

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

(2016) Yi-Yun Liu et al.   LANCET INFECTIOUS DISEASES

Polymyxin Resistance Caused bymgrBInactivation Is Not Associated with Significant Biological Cost in Klebsiella pneumoniae

(2015) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

(2015) Johann D. D. Pitout et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology and characterization of an outbreak causing Klebsiella pneumoniae clone carrying chromosomally located bla CTX-M-15 at a German University-Hospital

(2015) Stephen E. Mshana et al.   BMC MICROBIOLOGY

Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d’Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789)

(2015) Mariateresa Del Franco et al.   BMC MICROBIOLOGY

An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread

(2015) V. Weterings et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin

(2014) Aurélie Jayol et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance

(2014) Meredith S. Wright et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study

(2014) Abiola Olumuyiwa Olaitan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae

(2014) L. Poirel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement

(2014) Nigel Field et al.   LANCET INFECTIOUS DISEASES

In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator

(2013) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii

(2013) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395

(2013) J. Yang et al.   CLINICAL MICROBIOLOGY AND INFECTION

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study

(2012) L. Dalfino et al.   CLINICAL INFECTIOUS DISEASES

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy

(2012) Caterina Mammina et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Complete Genome Sequence of Klebsiella pneumoniae 1084, a Hypermucoviscosity-Negative K1 Clinical Strain

(2012) A.-C. Lin et al.   JOURNAL OF BACTERIOLOGY

First Outbreak of a Plasmid-Mediated Carbapenem-Hydrolyzing OXA-48 β-Lactamase in Klebsiella pneumoniae in Spain

(2011) Cristina Pitart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437

(2011) Liliane M. Seki et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Multiplex PCR for detection of acquired carbapenemase genes

(2011) Laurent Poirel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia

(2011) H. Lahlaoui et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Klebsiella pneumoniae Yersiniabactin Promotes Respiratory Tract Infection through Evasion of Lipocalin 2

(2011) Michael A. Bachman et al.   INFECTION AND IMMUNITY

Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel

(2010) A. Leavitt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns

(2010) Volker Strenger et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS